Article

Triggering the Interferon Antiviral Response Through an IKK-Related Pathway

Lady Davis Institute for Medical Research-Jewish General Hospital, Departments of Microbiology and Immunology and Medicine, McGill University, Montreal, Quebec H3T 1E2, Canada.
Science (Impact Factor: 31.48). 06/2003; 300(5622):1148-51. DOI: 10.1126/science.1081315
Source: PubMed

ABSTRACT Rapid induction of type I interferon expression, a central event in establishing the innate antiviral response, requires cooperative
activation of numerous transcription factors. Although signaling pathways that activate the transcription factors nuclear
factor κB and ATF-2/c-Jun have been well characterized, activation of the interferon regulatory factors IRF-3 and IRF-7 has
remained a critical missing link in understanding interferon signaling. We report here that the IκB kinase (IKK)–related kinases
IKKϵ and TANK-binding kinase 1 are components of the virus-activated kinase that phosphorylate IRF-3 and IRF-7. These studies
illustrate an essential role for an IKK-related kinase pathway in triggering the host antiviral response to viral infection.

Download full-text

Full-text

Available from: Rongtuan Lin, Aug 31, 2015
0 Followers
 · 
115 Views
 · 
237 Downloads
  • Source
    • "This observation is consistent with a previous report that 17β-estradiol can enhance the ability of STAT1 to bind to ISRE [66]. Multiple studies have reported that IKKε phosphorylates specific serine residues in the transcription factors IRF3 and IRF7 in response to virus infection [67] [68] and promotes formation of the IFN-β enhanceosome [69]. Interestingly, the severity and incidence of innate immune conditions, such as sepsis and post-surgery infections, are profoundly less in women compared with age-matched men [70] [71]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The activation of IFN-α signaling in B cells contributes to the pathogenesis of systemic lupus erythematosus (SLE). Many studies suggest that estrogens are closely related to the gender difference in the prevalence of SLE. However, the underlying mechanism of the interaction between estrogens and the activation of IFN-α signaling in SLE B cells remains incompletely understood. In the present study, we first found that healthy female mice showed an up-regulated type I IFN-induced gene signature in B cells compared with age-matched male mice, and in vivo study revealed that the gender difference was related to 17β-estradiol. Moreover, we found that 17β-estradiol could enhance the activation of IFN-α signaling in an ERα-dependent manner by down-regulating the expression of three microRNAs, including let-7e-5p, miR-98-5p and miR-145a-5p. These microRNAs could target the 3'UTR of the IKKε-encoding gene IKBKE directly and regulate the expression of IKKε, which can promote the activation of IFN-α signaling. In addition, compared with age-matched male mice, female mice showed a higher level of IKKε and lower levels of let-7e-5p, miR-98-5p and miR-145a-5p in B cells. Moreover, peripheral blood mononuclear cells from women showed a higher level of IKKε and lower levels of let-7e-5p, miR-98-5p and miR-145a-5p compared with those from age-matched men. These data suggest that 17β-estradiol amplifies the activation of IFN-α signaling in B cells via IKKε by down-regulating the expression of let-7e-5p, miR-98-5p and miR-145a-5p. Our findings may provide a new perspective for understanding the mechanism underlying the gender difference in the prevalence of SLE. Copyright © 2015. Published by Elsevier B.V.
    Biochimica et Biophysica Acta 04/2015; 1852(8). DOI:10.1016/j.bbadis.2015.04.019 · 4.66 Impact Factor
  • Source
    • "Among the genes whose expression was found defective in the absence of Ulk1/2 were Cxcl10 (Zhang et al., 2005) and Eif2ak2 (García et al., 2006; McAllister and Samuel, 2009), both of which are involved in the induction of antiviral effects and control of apoptosis. The induction of several other genes whose function was necessary for generation for IFN biological responses was also defective in Ulk1/2 À/À cells, including Irgm2 (Hunn et al., 2008), Gch1 (Rani et al., 2007; Alp and Channon , 2004), Ifit3 (Schmeisser et al., 2010; Liu et al., 2011); Oasl2 (Zhu et al., 2014), Irf7 (Sharma et al., 2003; Honda et al., 2005; Colina et al., 2008), Irf9 (Darnell et al., 1994; van Boxel-Dezaire et al., 2006), and Isg54/Ifit2 (Yang et al., 2012) (Figures 3A–3I). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We provide evidence that the Unc-51-like kinase 1 (ULK1) is activated during engagement of the type I interferon (IFN) receptor (IFNR). Our studies demonstrate that the function of ULK1 is required for gene transcription mediated via IFN-stimulated response elements (ISRE) and IFNγ activation site (GAS) elements and controls expression of key IFN-stimulated genes (ISGs). We identify ULK1 as an upstream regulator of p38α mitogen-activated protein kinase (MAPK) and establish that the regulatory effects of ULK1 on ISG expression are mediated possibly by engagement of the p38 MAPK pathway. Importantly, we demonstrate that ULK1 is essential for antiproliferative responses and type I IFN-induced antineoplastic effects against malignant erythroid precursors from patients with myeloproliferative neoplasms. Together, these data reveal a role for ULK1 as a key mediator of type I IFNR-generated signals that control gene transcription and induction of antineoplastic responses. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
    Cell Reports 04/2015; 11(4). DOI:10.1016/j.celrep.2015.03.056 · 8.36 Impact Factor
  • Source
    • "Represses TGF-b-Induced Transcription RLR-induced IRF3 activation results from the activities of TBK1 or IKKε that phosphorylate and thus activate IRF3 (Fitzgerald et al., 2003; Sharma et al., 2003). BX795, an inhibitor of TBK1 and IKKε (Clark et al., 2009), inhibited the activation of IRF3 (Figure 2A, 4 th lane), and restored the inhibition of TGF-b-induced transcription by TpIC (Figure 2B, lanes 3, 4). "
    [Show abstract] [Hide abstract]
    ABSTRACT: TGF-β signaling is essential in many processes, including immune surveillance, and its dysregulation controls various diseases, including cancer, fibrosis, and inflammation. Studying the innate host defense, which functions in most cell types, we found that RLR signaling represses TGF-β responses. This regulation is mediated by activated IRF3, using a dual mechanism of IRF3-directed suppression. Activated IRF3 interacts with Smad3, thus inhibiting TGF-β-induced Smad3 activation and, in the nucleus, disrupts functional Smad3 transcription complexes by competing with coregulators. Consequently, IRF3 activation by innate antiviral signaling represses TGF-β-induced growth inhibition, gene regulation and epithelial-mesenchymal transition, and the generation of Treg effector lymphocytes from naive CD4(+) lymphocytes. Conversely, silencing IRF3 expression enhances epithelial-mesenchymal transition, TGF-β-induced Treg cell differentiation upon virus infection, and Treg cell generation in vivo. We present a mechanism of regulation of TGF-β signaling by the antiviral defense, with evidence for its role in immune tolerance and cancer cell behavior. Copyright © 2014 Elsevier Inc. All rights reserved.
    Molecular Cell 12/2014; 56(6):723-737. DOI:10.1016/j.molcel.2014.11.027 · 14.46 Impact Factor
Show more